Check out upcoming events by this organizer, or organize your very own event.
LIFE SCIENCES FORUM - JANUARY 18, 2011
Tuesday, January 18, 2011 from 8:00 AM to 12:00 PM (EST)
New York, United States
The Keiretsu Forum Life Sciences Selection Committee is comprised of angel and venture capital investors, expert in the life sciences industry.
The Life Science Forum presentations are 25 minutes long:
After each entrepreneur presents, an Interest List is passed around the room and individual members who are interested in the company express their interest by signing in.
After all presentations are concluded, entrepreneurs are excused and Forum members discuss the companies.
Built on Patented System to Remove Skin Tags
Disposable Tweezer-Like Applicator Designed Specifically for Skin Tags
2) PreEmptive Meds, Inc
A Branded “Pharma-Nutraceutical” Company
2010 Revenue = $800,000
3) Cornerstone Pharma
Discovering and Developing Drugs to Target and Exploit the Altered Metabolism of Cancer. 3 ongoing PhaseI-I/II trials usingCPI-613
4) Immune Pharmaceuticals
Discovery, Development and Commercialization of Monoclonal Antibodies (mAbs)
- Bertilimumab, a Phase 2 anti-eotaxin 1 mAb, originally developed by CAT (now MedImmune), for the treatment of Inflammatory Bowel Disease - Crohn’s Disease and Ulcerative Colitis- and Severe Asthma.
- A Phase 1 anti-Fas mAb, to be co- developed with the Karolinska Institute, for the treatment of Graft vs. Host Disease following Bone Marrow Transplantation and of Toxic Epidermal Necrosis, a lethal orphan disease.
5) Business Performance Labs
Business Performance Labs provides predictive modeling and analytic software services to the very high value business process of pharmaceutical clinical studies
2010 revenue $1M
Prevention Pharmaceuticals will address the Central Nervous System (CNS) and Cardiovascular (CV) needs of the > 150 million Americans who take dietary supplements annually. 2010 revenue $450K
To refer a company to present at this meeting or any of our upcoming meetings please use our online application at http://angelsoft.net/angel-group/k4-newyork.
Keiretsu Forum is the world’s largest angel investor network with 850 accredited investor members throughout eighteen chapters on three continents. Since Keiretsu Forum’s founding in 2000, its members have invested over $190m in 200+ companies in technology, consumer products, healthcare/life sciences, real estate and other segments with high growth potential. Forum members collaborate in the due diligence, but make individual investment decisions, with rounds in the range of $250k-$10m.
Your message has been sent!
In order to purchase these tickets in installments, you'll need an Eventbrite account. Log in or sign up for a free account to continue.